Viewing Study NCT01805960


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-01-08 @ 12:36 AM
Study NCT ID: NCT01805960
Status: TERMINATED
Last Update Posted: 2017-02-14
First Post: 2013-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Canakinumab for the Prevention of Recurrences After Electrical Cardioversion: CONVERT-AF
Sponsor: University Hospital, Basel, Switzerland
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atrial Fibrillation View
Keywords: